FDA Inspection
Sanit Technologies, LLC dba DurisanSanit Technologies, LLC dba Durisan – FDA Inspection, Mar 5, 2021
Record Details
This FDA Inspection record concerns Sanit Technologies, LLC dba Durisan, with an inspection on March 5, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 5, 2021
- Product Type
- Drugs
View Company Profile
ID · 78ebe63b-ad66-4272-ac93-12c053a8eacb
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1136671
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
FDA Citations
5- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sanit Technologies, LLC dba Durisan
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 17, 2019 | VAI | Center for Drug Evaluation and Research | Over-the-Counter Drug Evaluation |
Other documents for Sanit Technologies, LLC dba Durisan
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.